Abstract:In this article, we present a new approach by merging two powerful synthetic tactics, divergent synthesis and cascade organocatalysis, to create a divergent cascade organocatalysis strategy for the facile construction of new "privileged" substructure-based DOS (pDOS) library. As demonstrated, notably 5 distinct molecular architectures are produced facilely from readily available simple synthons thiazolidinedione and its analogues and α,β-unsaturated aldehydes in 1-3 steps with the powerful strategy. The beauty of the chemistry is highlighted by the efficient formation of structurally new and diverse products from structurally close reactants under the similar reaction conditions. Notably, structurally diverse spiro-thiazolidinediones and -rhodanines are produced from organocatalytic enantioselective 3-component Michael-Michael-aldol cascade reactions of respective thiazolidinediones and rhodanines with enals. Nevertheless, under the similar reaction conditions, reactions of isorhodanine via a Michael-cyclization cascade lead to structurally different fused thiopyranoid scaffolds. This strategy significantly minimizes time- and cost-consuming synthetic works. Furthermore, these molecules possess high structural complexity and functional, stereochemical, and skeletal diversity with similarity to natural scaffolds. In the preliminary biological studies of these molecules, compounds 4f, 8a, and 10a exhibit inhibitory activity against the human breast cancer cells, while compounds 8a, 9a, and 9b display good antifungal activities against Candida albicans and Cryptococcus neoformans. Notably, their structures are different from clinically used triazole antifungal drugs. Therefore, they could serve as good lead compounds for the development of new generation of antifungal agents.

Heterocycle-Thioacetic Acid Motif: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activities

Diverse Biological Activities of 1,3,4-Thiadiazole Scaffold

Synthetic Transformations and Medicinal Significance of 1,2,3-Thiadiazoles Derivatives: An Update

Chromones: Privileged scaffold in anticancer drug discovery

Cyclopropyl Scaffold: A Generalist for Marketed Drugs

A Multifaceted Scaffold for Building Bioactive Compounds: Phenothiazine

Functionalized heterocyclic scaffolds derived from Morita-Baylis-Hillman Acetates.

The Chromenopyridine Scaffold: A Privileged Platform in Drug Design

Thiazole moiety: A promising scaffold for anticancer drug discovery

Heterocyclic Iodoniums As Versatile Synthons To Approach Diversified Polycyclic Heteroarenes

Chalcone: A Privileged Structure in Medicinal Chemistry

Vinyl and Alkynyl Substituted Heterocycles as Privileged Scaffolds in Transition Metal Promoted Stereoselective Synthesis

Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide

Facile Construction of Structurally Diverse Thiazolidinedione-Derived Compounds Via Divergent Stereoselective Cascade Organocatalysis and Their Biological Exploratory Studies.

Novel Spiropyrazolone Antitumor Scaffold with Potent Activity: Design, Synthesis and Structure–activity Relationship

Tetrazoles: A multi-potent motif in drug design

Pyrrolotriazinone as an Underexplored Scaffold in Drug Discovery

Oxygen-, Nitrogen-, and Sulfur-Containing Heterocycles: Recent Advances in De Novo Synthesis and Prospect

α,β-Bifunctionalized carbonyl compounds as privileged motifs in drug discovery and their synthetic protocols

Have spirocyclic scaffolds been properly utilized in recent drug discovery efforts?

Biological activity of oxadiazole and thiadiazole derivatives